INFLUENCE OF THE DRUG OMNIC ON THE INTENSITY OF CELLULAR REACTIONS IN THE SPOTS OF EXPERIMENTAL INFLAMMATION
https://doi.org/10.57256/2949-0715-2024-4-40-49
Abstract
Relevance. The effect of the drug Omnic (Tamsulosin) reduces the tone of the smooth muscles of the prostate gland, bladder neck, prostatic part of the urethra, improves urine flow, reduces the symptoms of obstruction and irritation of the urinary tract in benign prostatic hypertrophy. However, there are no data on its anti-inflammatory effect.
Objective. To determine the mechanisms of the anti-inflammatory effect of the drug Omnic on the model of purulent inflammation in rats.
Material and methods. The study was conducted on 50 outbred white male rats divided into 2 series: Series 1 - control (they were implanted with diffusion chambers filled with an aqueous suspension of a one-day culture of staphylococcus aureus under the skin of the thigh; Series 2 - experimental (the animals of this series were modeled with purulent inflammation similar to the control, but from the 1st day of inflammation, the rats were injected intramuscularly with 0.02 ml of the Omnic preparation for 10 days). The materials were collected 2, 3, 5, 7, 10, 15, 20, 30, 60 days after implantation. The material was fixed in a 10 % solution of neutral formalin. In the peripheral zone of the inflammation focus, the state of the microvessels was qualitatively assessed, the concentration of mast cells, eosinophils, neutrophils, mononuclear cells and poorly differentiated fibroblasts was counted.
Results. After 48 Hours after the onset of inflammation, a cellular wall with a thickness of 313.18 ± 30.19 μm is observed around the chamber wall. Three days after the introduction of the chambers, the thickness of the leukocyte wall remains the same and is 334.38 ± 25.69 μm. Five days after the onset of inflammation, the thickness of the leukocyte wall decreases sharply compared to the previous period and is 157.86 ± 46.08 μm. Seven days after the introduction of the chambers, the thickness of the cellular wall increases to 220 ± 29.67 μm. On the 10th day from the onset of inflammation, the thickness of the wall decreases to 129.52 ± 21.01 μm. On the 15th day of inflammation, the thickness and condition of the leukocyte wall do not change. On days 20-30-60 from the moment of implantation of the chambers, the remains of the leukocyte shaft with a thickness of 117.86 ± 29.6 μm were observed around them.
Conclusion. The effect of Omnic on the dynamics of cellular reactions in the inflammation focus enhances the migration capacity of leukocytes, concentrates fibroblasts around the leukocyte shaft. At the same time, the synthesis of collagen by fibroblasts does not correspond to the thickness of the connective tissue capsule, which disrupts the maturation process of the capsule. Presumably, the action of Omnic is associated with the effect of the drug on the tone of capillaries and venules
About the Authors
Igor Zh. SeminskyRussian Federation
Dr. Sci. (Med.), Professor, Head of the Department of Pathological Physiology and Clinical Laboratory Diagnostics, Irkutsk State Medical University, Russia, 664003, Irkutsk, st. Krasnogo Vosstaniya, 1. ORCID: 0000-0002-5982-3875
Svetlana N. Serebrennikova
Russian Federation
Cand. Sci. (Med.), Associate Professor, Department of Pathological Physiology and Clinical Laboratory Diagnostics, Irkutsk State Medical University, Russia, 664003, Irkutsk, st. Krasnogo Vosstaniya, 1. ORCID:0000-0003-3328-4727
Elena A. Tkachuk
Russian Federation
Dr. Sci. (Med.), Associate Professor, Professor of the Department of Pathological Physiology and Clinical Laboratory Diagnostics, Irkutsk State Medical University, Russia, 664003, Irkutsk, st. Krasnogo Vosstaniya, 1; Senior Researcher, «Scientific Center for Family Health and Human Reproduction Problems», Russia, 664003, Irkutsk, Timiryazeva St., 16; Leading Researcher, «East Siberian Institute of Medical and Ecological Research», Russia, 665826, Angarsk, microdistrict 12a, building 3. ORCID: 0000-0001-7525-2657
Yuri V. Vasiliev
Russian Federation
Dr. Sci. (Med.), Professor, Irkutsk State Medical Academy of Postgraduate Education - branch of the Federal State Budgetary Educational Institution of Higher Professional Education, Russian Medical Academy of Postgraduate Education, Russia, 664049, Irkutsk, microdistrict. Yubileiny, 100
References
1. Пушкарь Д.Ю., Лоран О.Б., Раснер П.И. Терапия альфа-адреноблокаторами – метод выбора в лечении обструктивного мочеиспускания у мужчин и женщин. Урол. и андрол. 2002; 10 (61).
2. Мазо Е.Б., Белковская М.Н. Фармакотерапия доброкачественной гиперплазии простаты. Рус. мед. журн. 2001; 9 (16–17).
3. Регистр лекарственных средств: http://www.rlsnet.ru/registration.html.
4. Данилов В.В., Елисеева Е.В., Данилов В.В. / К вопросу механизма действия альфа1-адреноблокаторов // РМЖ., 2010 № 2. Т. 17. С. 109-113.
5. Kortmann BBM, Floratos DL, Kiemeney LA et al. Urodynamic effects of alpha-adrenoceptor blockers: a review of clinical trials. Urology 2003 Jul;62(1):1–9 (Level 4). http://www.ncbi.nlm.nih.gov/pubmed/12837408
6. Hu ZW, Shi XY, Hoffman BB. Doxazosin inhibits proliferation and migration of human vascular smooth-muscle cells independent of alpha1-adrenergic receptor antagonism. J Cardiovasc Pharmacol. 1998 Jun;31(6):833-9. doi: 10.1097/00005344-199806000-00006. PMID: 9641467.
7. Johnson R, Webb JG, Newman WH, Wang Z. Regulation of human vascular smooth muscle cell migration by beta-adrenergic receptors. Am Surg. 2006 Jan;72(1):51-4. PMID: 16494183.
8. Xiao Q, Liu QM, Jiang RC, Chen KF, Zhu X, Ma L, Li WX, He F, Huang JJ. Piperazine-Derived α1D/1A Antagonist 1- Benzyl-N- (3-(4- (2-Methoxyphenyl) Piperazine-1-yl) Propyl) -1H- Indole-2- Carboxamide Induces Apoptosis in Benign Prostatic Hyperplasia Independently of α1-Adrenoceptor Blocking. Front Pharmacol. 2021 Jan 27;11:594038. doi: 10.3389/fphar.2020.594038. PMID: 33584271; PMCID: PMC7873900.
9. Martin FM, Harris AM, Rowland RG, Conner W, Lane M, Durbin E, Baron AT, Kyprianou N. Decreased risk of bladder cancer in men treated with quinazoline-based α1-adrenoceptor antagonists. Gene Ther Mol Biol. 2008;12(2):253-258. PMID: 20717483; PMCID: PMC2921713.
10. Yang X, Thomas DP, Zhang X, Culver BW, Alexander BM, Murdoch WJ, Rao MN, Tulis DA, Ren J, Sreejayan N. Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation. Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):85-90. doi: 10.1161/01.ATV.0000191635.00744.b6. Epub 2005 Oct 20. PMID: 16239599.
11. Pukac L, Huangpu J, Karnovsky MJ. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration. Exp Cell Res. 1998 Aug 1;242(2):548-60. doi: 10.1006/excr.1998.4138. PMID: 9683541.
12. Boesch ST, Corvin S, Zhang J, Rogatsch H, Bartsch G, Klocker H. Modulation of the differentiation status of cultured prostatic smooth muscle cells by an alpha1-adrenergic receptor antagonist. Prostate. 1999 Jun 1;39(4):226-33. doi: 10.1002/(sici)1097-0045(19990601)39:4<226::aid-pros2>3.0.co;2-8. PMID: 10344211.
13. Liu QM, Xiao Q, Zhu X, Chen KF, Liu XW, Jiang RC, Wu D, Shi JM, Dai LJ, Huang JJ. Inhibitory effect of α1D/1A antagonist 2-(1H-indol-3-yl)-N-[3-(4-(2-methoxyphenyl) piperazinyl) propyl] acetamide on estrogen/androgen-induced rat benign prostatic hyperplasia model in vivo. Eur J Pharmacol. 2020 Mar 5;870:172817. doi: 10.1016/j.ejphar.2019.172817. Epub 2019 Nov 19. PMID: 31756334.
14. Kappert K, Sparwel J, Sandin A, Seiler A, Siebolts U, Leppänen O, Rosenkranz S, Ostman A. Antioxidants relieve phosphatase inhibition and reduce PDGF signaling in cultured VSMCs and in restenosis. Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2644-51. doi: 10.1161/01.ATV.0000246777.30819.85. Epub 2006 Sep 21. PMID: 16990553.
15. Kappert K, Paulsson J, Sparwel J, Leppänen O, Hellberg C, Ostman A, Micke P. Dynamic changes in the expression of DEP-1 and other PDGF receptor-antagonizing PTPs during onset and termination of neointima formation. FASEB J. 2007 Feb;21(2):523-34. doi: 10.1096/fj.06-6219com. Epub 2006 Dec 8. PMID: 17158785.
Review
For citations:
Seminsky I.Zh., Serebrennikova S.N., Tkachuk E.A., Vasiliev Yu.V. INFLUENCE OF THE DRUG OMNIC ON THE INTENSITY OF CELLULAR REACTIONS IN THE SPOTS OF EXPERIMENTAL INFLAMMATION. Baikal Medical Journal. 2024;3(4):40-49. (In Russ.) https://doi.org/10.57256/2949-0715-2024-4-40-49